Michael Hiltzik, Los Angeles Times; Column: COVID-19 could kill the for-profit science publishing model. That would be a good thing
"The current crisis has demonstrated the value of open access to research, as well as the drawbacks of secrecy."
The Paperback version of my Bloomsbury book "Ethics, Information, and Technology" will be published on Nov. 13, 2025; the Ebook on Dec. 11; and the Hardback and Cloth versions on Jan. 8, 2026. Preorders are available via Amazon and this Bloomsbury webpage: https://www.bloomsbury.com/us/ethics-information-and-technology-9781440856662/
Showing posts with label coronaviruses. Show all posts
Showing posts with label coronaviruses. Show all posts
Thursday, March 5, 2020
Friday, February 7, 2020
Chinese scientists ask for patent on US drug to fight virus; Associated Press, February 6, 2020
Joe McDonald and Linda A. Johnson, Associated Press; Chinese scientists ask for patent on US drug to fight virus
"China has the right 
under World Trade Organization rules to declare an emergency and compel a
 company to license a patent to protect the public. It would be required
 to pay a license fee that is deemed fair market value. 
The
 government might be able to avoid that fee if the patent were granted 
to the Wuhan institute, part of the elite Chinese Academy of Sciences. 
The
 institute said it applied for a “use patent” that specifies the Wuhan 
virus as the drug’s target. Gilead’s patent application, filed before 
the virus was identified, cites only the overall family of 
coronaviruses."
Subscribe to:
Comments (Atom)
